Background: Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes (T2DM),
reduced hemoglobin A 1c (A1C) and weight in clinical trials. The objective of this study …

… Bowlus consults and received grants from Intercept, GlaxoSmithKline, and Bristol-Myers
Squibb. He consults for Conatus, Patara, and Eli Lilly. He received grants from Gilead, CymaBay…

Background Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized
by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. …

Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary
disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of …

Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to
fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation 1 , 2 , …

Primary biliary cirrhosis is a chronic liver disease characterised by intrahepatic bile-duct
destruction, cholestasis, and, in some cases, cirrhosis. Evidence supporting the autoimmune …

BACKGROUND:: Exenatide, an incretin mimetic for adjunctive treatment of type 2 diabetes
mellitus (T2DM), reduced glycosylated hemoglobin (HbA 1c ) and weight in 30-week placebo-…

CD4 + CD25 high regulatory T cells (Tregs) play a critical role in self‐tolerance, as seen in
murine autoimmunity. Studies on Tregs in human autoimmunity have focused primarily on …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH, autoimmune
hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; AST, …

Primary sclerosing cholangitis (PSC) is a rare progressive disorder leading to bile duct
destruction; ∼75% of patients have comorbid inflammatory bowel disease (IBD). We undertook …